Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
University of Chicago
University of Chicago
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Washington University School of Medicine
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
University of Leipzig
Roswell Park Cancer Institute